EMA Makes Final Preparations Ahead of New EudraVigilance Launch
By Michael Mezher -
Published 04 October 2017
With the 22 November launch date for its revamped EudraVigilance system rapidly approaching, the European Medicines Agency (EMA) on Wednesday provided some last minute updates on what to expect during the transition to the new system.
Categories: News, Europe, EMA, Biologics and biotechnology, Drugs, Postmarket surveillance
Tags: EudraVigilance, Pharmacovigilance, ICSRs, SUSARs, Adverse Event Reporting